doi: American Diabetes Association Professional Practice Committee
In the Veterans Health Administration (VHA) national dataset, an adjusted OR indicated no significant difference in pancreatitis occurrences between thiazolidinedione and incretin groups (adjusted OR, 0.94
10.1002/psc.3351 4 BatterhamR
In fact her boss, Mads Krogsgaard Thomsen, remembers that top management gave them only one year 'to come up with a GLP-1 candidate for daily administration to people with type 2 diabetes' (Holst 2024)
This is thought to be because these medications impact the brain's hypothalamus, which is basically the brain's control center because it regulates mood, hunger, thirst and body temperature
People who tap these blockbuster medications, which mimic a naturally produced hormone called GLP-1, lose an average of 15% to 20% of their body weight